BOSTON, Mass. – July 12, 2022 – Etiometry, a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care. Etiometry is the only critical care AI decision-support company […]

Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON, Mass. & BREA, Cal. – June 30, 2022 – Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical […]

Healthcare providers across Canada can now implement the IDO2 Index for adult patients in the ICU, which provides a risk estimation of inadequate oxygen delivery June 06, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, today announced the first market authorization of the company’s IDO2 Index […]

Leading Intensive Care Clinical Decision-Support Solution Secures New Funding and Inks Strategic Collaborations and Clients to Fuel Expansion BOSTON – January 20, 2022 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today announced substantial business growth and expansion in 2021. The successful year for Etiometry included achieving new sales milestones, inking […]